Thermo Fisher Scientific: TMO Analyst Day Preview: What to expect from this week’s big event

Research evidence excerpt

Thermo Fisher Scientific: TMO Analyst Day Preview: What to expect from this week’s big event

Accessible version

Thermo Fisher Scientific

TMO Analyst Day Preview: What to expect

from this week’s big event

Maintain Rating: BUY | PO: 630.00 USD | Price: 442.00 USD

05/20 Analyst Day comes as Tools face continued pressure 19 May 2026

Tomorrow, Wednesday 05/20/26, we’ll be attending Thermo Fisher Scientific’s (TMO) Equity

2026 Analyst Day in New York City. TMO’s Analyst Days were an annual tradition for

Michael Ryskin

years, in many ways setting the tone for the rest of the Tools space, but TMO skipped Research Analyst

the event in 2025, and there are many questions on what this year’s event will bring. BofAS +1 646 855 4373

While there is a broader view that market conditions are slowly starting to normalize, michael.ryskin@bofa.com

there’s still a great amount of uncertainty across Tools space. Commentary from TMO Avantika Dhabaria

on the pace of recovery and overall status of key markets is likely to drive overall Research Analyst BofAS

sentiment for the space for the rest of 2026 and into 2027. However, after facing +1 646 743 0170

continued pressure and headwinds, we think investors will be looking for tangible drivers avantika.dhabaria@bofa.com

of accelerating demand – and the long-awaited ‘return to normal.’ We maintain our Buy AlexaResearchChanAnalyst

rating as we think TMO is well-positioned, and find current valuation compelling. BofAS

+1 646 855 5636

LRP update? We think unlikely alexa.chan@bofa.com

We’ve fielded a number of questions whether TMO will update their LRP (long range

plan), but we think that’s unlikely. Back in 2021, TMO had raised its LRP to a 7-9%

Stock Dataorganic sales growth CAGR (vs prior 5-7%), where it remained unchanged until 2Q25 –